Leading National CRO

Cognitive Research Corp.

Cognitive Research Corporation (CRC) is a privately-held, full-service contract research organization that specializes in Central Nervous System (CNS) product development for pharmaceutical, nutraceutical, biotechnology and medical device companies. With offices in Florida and an integrated network of experienced research facilities, CRC is well-positioned to conduct clinical studies at any stage, Phase I-IV.

two researchers walking down the hall looking at a laptop
Digital rendition of a brain

Clinical Trial Management

CRC provides comprehensive CRO services with a focus on maintaining a personal connection with our clients.

Trial Design

Lorem ipsum dolor sit amet consectetur adipiscing elit

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. 
Click here

Clinical Trial Management

Lorem ipsum dolor sit amet consectetur adipiscing elit

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. 
Click here

Quality Assurance

Lorem ipsum dolor sit amet consectetur adipiscing elit

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. 
Click here

Clinical Trial Management

We support you throughout the trial with project management

Find out more about our how we partner with our clients to manage the entire trial process.
Find out more

Biostatistics

We analyze your data and create statistical analysis plans

From Statistical Analysis Plans to Meta Analysis, we offer a range of biostatistical analysis.
Find out more

Trial Design

We offer consulting and protocol development

Contact us to find out more about trial design and how we partner with you to create the most effective trial plan.
Contact us

Medical Writing

We collaborate in the development of CSRs and abstracts

From CSRs to NDA development, we offer highly specialized, experienced medical writing.
Find out more

Data Management

Deep expertise coding and designing trial research data systems

Find out more about our expertise in data management.
Find out more

Regulatory Affairs

We manage regulatory documents and submission

Regulatory submissions require strict adherence to guidelines and procedures. We can manage the process to assure accurate, timely submission.
Find out more

Quality Assurance

We manage the quality of our trials through various audits

Contact us for more information on our quality assurance audits, clinical file audits and investigator audits.
Contact us

Media Services

We help bring exposure to your trial research through full media support

We offer continuing education programs; invited Addresses; and TV, Radio, Print Strategy & Design.
Contact Us
CRCDS Driving Simulator
CRCDS Driving Simulator
The CRCDS

Driving Simulation Studies

CRC’s customized driving simulator (the CRCDS) is used to evaluate the effects of age, trauma, neurologic disease, alcohol and fatigue on driving performance. The CRCDS is also designed to study the effects of a wide variety of drugs on driving abilities in both normal and patient populations.

WE'RE HIRING

Interested in working for the leading National CRO?
Find out more below.

NEWS

Stay up to date on our newest trials, events and industry news

PRESS RELEASE – Cognitive Research Corporation assists BioXcel on FDA approval of IGALMI™.

CRC partnered with BioXcel Therapeutics on FDA approval of IGALMI™ (dexmedetomidine) sublingual film for acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults. This program was from first-in-human trials through NDA approval. With this approval, BioXcel becomes the first and only FDA-approved orally dissolving sublingual film for mild, moderate, or severe agitation in patients with schizophrenia or bipolar disorder. Tom Hochadel, President of CRC, commented, “It is very rare for a clinical service company to work with a sponsor from first-in-human to NDA approval of a new drug. CRC and BioXcel have been collaborating on this program since 2018 and have worked cohesively and rapidly to move this innovative new therapy to approval. CRC is proud of their ability to deliver scientific and clinical development expertise to this program.”

Read More
woman in front of multiple monitors

PRESS RELEASE – Cognitive Research Corporation Names C. Gordon “Chip” Gillooly as New CEO

Cognitive Research Corporation (CRC), a leading neuroscience clinical services company, announced that C. Gordon “Chip” Gillooly has been named Chief Executive Officer. Mr. Gillooly succeeds Dr. Tom Hochadel, Co-Founder, who will now serve as President and will continue to play an integral role in the company’s growth and delivery of exceptional CRO services to our clients. Dr. Gary Kay, Co-Founder and Head of Psychometric Assessments, will remain Chief Science Officer. CRC has been supporting clinical development for CNS-focused small to mid-size pharma, biotech, and medical device companies for over 16 years. The company has experienced explosive growth over the past five years as the CNS market has accelerated.

Read More

Keep in touch with the trends

Sign up to receive email newsletters, notifications of events, and other information from Cognitive Research Corporation